Clinical Trials List
Protocol Number103-2853A
Completed
2016-12-01 - 2025-09-11
Phase I
Terminated1
-
Sponsor
-
Trial scale
Taiwan Single Center
-
Update
2026/03/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
20 participants
-
Global
0 participants
